Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.50 is 260% above its 4-year average of -0.31, near the high end of its 4-year range (-0.76–0.50).
As of the fiscal period ended Wednesday, December 31, 2025. 566.67% above its 12-month average of 0.08.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.12.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 9 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T20:28:08.421Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.50
EARNINGS PER SHARE (EPS) AVG TTM
0.08
EARNINGS PER SHARE (EPS) AVG 3Y
-0.25
EARNINGS PER SHARE (EPS) AVG 5Y
-0.31
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+566.67%
CURRENT VS 3Y AVG
+302.02%
CURRENT VS 5Y AVG
+260.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Strata Critical Medical, Inc.
Market Cap
$411.00M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$411.21M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
Market Cap
$406.58M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$415.98M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.86
3Y Avg
-1.02
5Y Avg
-1.51
Market Cap
$405.74M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$416.27M
Earnings Per Share (EPS)
-2.27
TTM Avg
-2.08
3Y Avg
-0.07
5Y Avg
-5.01
Market Cap
$404.24M
Earnings Per Share (EPS)
-1.19
TTM Avg
-2.69
3Y Avg
-2.49
5Y Avg
-2.21
Market Cap
$418.95M
Earnings Per Share (EPS)
-0.75
TTM Avg
-2.34
3Y Avg
-2.48
5Y Avg
-2.46
Market Cap
$402.17M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Strata Critical Medical, Inc. (SRTA) | $411.00M | 0.50 | 0.08 | -0.25 | -0.31 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | -5.18 | -2.77 | -1.90 | -1.90 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | -4.63 | -6.16 | -6.16 | -6.16 |
| Rezolute, Inc. (RZLT)vs › | $415.98M | -0.76 | -0.86 | -1.02 | -1.51 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | -2.08 | -1.97 | -1.74 | -0.94 |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -2.27 | -2.08 | -0.07 | -5.01 |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -1.19 | -2.69 | -2.49 | -2.21 |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -0.75 | -2.34 | -2.48 | -2.46 |
| Neurogene Inc. (NGNE)vs › | $402.17M | -5.51 | -4.26 | -3.91 | -2.87 |
| Prothena Corporation plc (PRTA)vs › | $419.87M | -0.84 | -3.40 | -3.01 | -2.22 |
Trailing EPS (TTM)
$0.50
Forward EPS (Est.)
$-0.09
P/E Ratio
9.5
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.50 |
| 2024-12-31 | -0.35 |
| 2023-12-31 | -0.76 |
| 2022-12-31 | -0.38 |
| 2021-09-30 | -0.57 |
| 2020-09-30 | -0.81 |
| 2019-09-30 | -1.47 |
